The Rising Demand For Neurological Disorders Drives The Growth Of The Market Due To The Increasing Prevalence And Need For Symptom Management Is Supporting Development Across The Synthetic Cannabinoids Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Value Trend Is Expected For The Synthetic Cannabinoids Market From 2026 To 2030?

The market for synthetic cannabinoids has experienced substantial expansion in recent times. This market is projected to expand from $2.2 billion in 2025 to $2.59 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 17.6%. Key factors contributing to its historical growth include the constraints of plant-derived cannabinoids, the necessity for potency regulation, requirements for pharmaceutical research, the rise in pain management treatments, and specific regional regulatory acceptances.

The synthetic cannabinoids market size is projected to experience substantial growth in the upcoming years. It is anticipated to reach a valuation of $4.91 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. This projected expansion during the forecast period is due to factors such as the broader availability of medical cannabis, the rise in controlled cannabinoid therapeutics, the need for precision dosing, the scalability of synthetic APIs, and increased pharmaceutical R&D investments. Significant developments expected in this period encompass the spread of pharmaceutical-grade cannabinoids, expanding research into synthetic cannabinoids, a rising need for high-purity products, a move towards regulated medical applications, and improvements in controlled synthesis methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

Which Growth Factors Are Strengthening The Synthetic Cannabinoids Market Landscape?

The escalating requirement for treatments targeting neurological disorders is projected to propel the future expansion of the synthetic cannabinoids market. These conditions encompass diseases of the brain, spinal cord, and nerves, which disrupt movement, sensation, cognition, or overall bodily function. The rising occurrence of neurological disorders is predominantly attributed to the global aging population, as ailments like Alzheimer’s grow more prevalent with age due to cerebral aging and cumulative cellular damage. Synthetic cannabinoids engage cannabinoid receptors in the brain, aiding in the regulation of neurotransmitter activity and potentially mitigating symptoms linked to neurological disorders. For example, in September 2024, the European Brain Council, a health organization based in Belgium, reported that 7 million people in Europe currently live with Alzheimer’s disease, a figure expected to double to 14 million by 2030 due to an aging population, making it a considerable global public health challenge. Consequently, the increasing demand for neurological disorder treatments is driving the growth of the synthetic cannabinoids market.

What Segment Types Are Included In The Synthetic Cannabinoids Market Analysis?

The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids

2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals

3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications

4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids

2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Trends Are Contributing To Changes In The Synthetic Cannabinoids Market?

Key players within the synthetic cannabinoids market are concentrating their efforts on creating secure and superior products, including novel psychoactive substances, with the aim of minimizing associated health dangers and enhancing their market standing. Novel psychoactive substances are defined as designer drugs fabricated in laboratories, designed to imitate the effects of conventional illegal drugs, yet employing modified chemical structures to bypass detection and regulatory oversight. Illustratively, in December 2023, Quest Diagnostics Inc., a US-based healthcare company, introduced an innovative 88-compound Novel Psychoactive Substance (NPS) Test Panel, facilitating more precise identification of various synthetic cannabinoids and other designer drugs. This novel mass-spectrometry-based testing solution offers enhanced detection for evolving synthetic cannabinoids, thereby assisting healthcare providers in gaining a clearer comprehension of patient exposure and optimizing treatment choices. The implementation of these advanced diagnostic tools underscores an increasing demand for dependable monitoring mechanisms as synthetic cannabinoids continue their progression, thereby guaranteeing elevated safety, clarity, and adherence to regulations throughout the market.

Who Are The Businesses Driving Activity In The Synthetic Cannabinoids Market?

Major companies operating in the synthetic cannabinoids market are Cayman Chemical, Cerilliant Corporation, Restek Corporation, Chiron AS, BayMedica, CB Therapeutics Inc., Skye Bioscience, Zynerba Pharmaceuticals Inc., Botanix Pharmaceuticals, Kannalife Sciences Inc., SciSparc Ltd., Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd., BioVectra, Noramco Inc., Purisys LLC, Lygos Inc., Johnson Matthey, Almac Group, Cambrex Corporation

Access The Complete Synthetic Cannabinoids Market Report:

https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Region Accounts For The Highest Share Of The Synthetic Cannabinoids Market?

North America was the largest region in the synthetic cannabinoids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Synthetic Cannabinoids Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

Browse Through More Reports Similar to the Global Synthetic Cannabinoids Market 2026, By The Business Research Company

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795